(1)
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis. FE 2024, 25 (1). https://doi.org/10.7175/fe.v25i1.1568.